QSS
PCRX icon

Quantitative Systematic Strategies’s Pacira BioSciences PCRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,200
Closed -$350K – 623
2019
Q3 		$350K Buy
+9,200
New +$367K 0.08% 305
2016
Q3 		– Sell
-7,971
Closed -$299K – 460
2016
Q2 		$299K Buy
+7,971
New +$392K 0.14% 210
2016
Q1 		– Sell
-9,089
Closed -$700K – 665
2015
Q4 		$700K Buy
+9,089
New +$515K 0.19% 132

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Quantitative Systematic Strategies's PCRX Position: Q4 2019 in Review

Quantitative Systematic Strategies sold out of Pacira BioSciences (PCRX) in Q4 2019, closing a stake of 9,200 shares — an estimated $350K sold.

Quantitative Systematic Strategies first reported a position in PCRX in Q4 2015 and held it in 3 quarters. The position peaked at $700K in Q4 2015. 231 funds tracked by Wall St. Rank hold PCRX as of Q4 2019.

  • Quantitative Systematic Strategies reported no remaining Pacira BioSciences position as of Q4 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 9,200 Pacira BioSciences shares in Q4 2019, an estimated $350K.
  • Quantitative Systematic Strategies first reported a position in Pacira BioSciences in Q4 2015 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Pacira BioSciences position peaked at $700K in Q4 2015.
  • 231 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2019, filed 11 Feb 2020.